» Articles » PMID: 34779876

Research Progress on the Occurrence and Therapeutic Mechanism of Ferroptosis in NSCLC

Overview
Specialty Pharmacology
Date 2021 Nov 15
PMID 34779876
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Ferroptosis refers to a novel way of cell death, inconsistent with the conventional concept of apoptosis and necrosis. It shows a close association with iron metabolism and oxidative damage, as marked by the significant increase of reactive oxygen species, the decreases of mitochondrial volume, and the thickening of membrane density. Recent studies confirmed that ferroptosis is closely associated with the occurrence, development, and therapy of the tumors. As impacted by the high levels of reactive oxygen species and lipid peroxides in lung cancer tissues, it is suggested that ferroptosis is more likely to occur in lung cancer tissues, which may act as a novel approach for non-small cell lung cancer (NSCLC) therapy. In the present study, the research achievements in recent years on the regulating mechanism of ferroptosis and its effect on the occurrence and the therapy of lung cancer are reviewed.

Citing Articles

NUP155 and NDC1 interaction in NSCLC: a promising target for tumor progression.

Li K, Meng L, Yang Z, Hu W Front Pharmacol. 2024; 15:1514367.

PMID: 39720592 PMC: 11666513. DOI: 10.3389/fphar.2024.1514367.


Potentially functional variants of PARK7 and DDR2 in ferroptosis-related genes predict survival of non-small cell lung cancer patients.

Wang H, Liu H, Tang X, Lu G, Luo S, Du M Int J Cancer. 2024; 156(4):744-755.

PMID: 39319523 PMC: 11661923. DOI: 10.1002/ijc.35197.


Distinct roles and molecular mechanisms of nicotine and benzo(a)pyrene in ferroptosis of lung adenocarcinoma and lung squamous cell carcinoma.

Wen M, Zheng H, Zhao Y, Xia P Tob Induc Dis. 2024; 22.

PMID: 38947555 PMC: 11214278. DOI: 10.18332/tid/189490.


Induction of ferroptosis by natural products in non-small cell lung cancer: a comprehensive systematic review.

Zhang Q, Xia Y, Wang F, Yang D, Liang Z Front Pharmacol. 2024; 15:1385565.

PMID: 38751790 PMC: 11094314. DOI: 10.3389/fphar.2024.1385565.


Difference of serum tumor markers in different clinical stages of elderly patients with non-small cell lung cancer and evaluation of diagnostic value.

Qin W, Wang P, Ding C, Peng F J Med Biochem. 2023; 42(4):607-615.

PMID: 38084245 PMC: 10710819. DOI: 10.5937/jomb0-39798.


References
1.
Alvarez S, Sviderskiy V, Terzi E, Papagiannakopoulos T, Moreira A, Adams S . NFS1 undergoes positive selection in lung tumours and protects cells from ferroptosis. Nature. 2017; 551(7682):639-643. PMC: 5808442. DOI: 10.1038/nature24637. View

2.
Anderson G, Frazer D . Current understanding of iron homeostasis. Am J Clin Nutr. 2017; 106(Suppl 6):1559S-1566S. PMC: 5701707. DOI: 10.3945/ajcn.117.155804. View

3.
Bersuker K, Hendricks J, Li Z, Magtanong L, Ford B, Tang P . The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature. 2019; 575(7784):688-692. PMC: 6883167. DOI: 10.1038/s41586-019-1705-2. View

4.
Chen L, Li X, Liu L, Yu B, Xue Y, Liu Y . Erastin sensitizes glioblastoma cells to temozolomide by restraining xCT and cystathionine-γ-lyase function. Oncol Rep. 2015; 33(3):1465-74. DOI: 10.3892/or.2015.3712. View

5.
Chen P, Wu Q, Feng J, Yan L, Sun Y, Liu S . Erianin, a novel dibenzyl compound in Dendrobium extract, inhibits lung cancer cell growth and migration via calcium/calmodulin-dependent ferroptosis. Signal Transduct Target Ther. 2020; 5(1):51. PMC: 7205607. DOI: 10.1038/s41392-020-0149-3. View